Clinical trial · Observational
BRIANSTORM - Early Identification of Patients With Brain Metastases
NCT05185557CI-TRIAL-00063642unknownClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
A single arm observational study investigating the incidence of brain metastasis in patients with cancer recti and lung metastasis
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Brain Metastases | — | UNRESOLVED | — |
| Metastatic Rectal Adenocarcinoma | Rectal Adenocarcinoma | CURATED_BROADER | 0.78 |
Interventions
Interventions (0)
Data not yet available
No intervention recorded.
Design
Arms and outcomes
Arms (0)
[]Primary outcomes (1)
- measure
- Incidence of brain metastasis
- timeFrame
- 2 years
- description
- Incidence of brain metastasis in a high risk selected group
Secondary outcomes (4)
- measure
- Number of brain metastases eligible for local treatment options
- timeFrame
- 2 years
- description
- Number of brain metastases eligible for local treatment options
- measure
- Median two year overall survival
- timeFrame
- 2 years last patient
- description
- Median two year overall survival
- measure
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Primary rectal tumor location * Diagnosis of lung metastasis made by histo- or cytopathology, or by clinical and imaging criteria. * Able to understand written information * Consent to samples for translational research Exclusion Criteria: * Contraindications for MRI Priorly treated or known brain metastases
References
Publications (0)
Data not yet available
No reference posted for this study.